Back to mobile site

Moderna (MRNA) Reports Q2 Revenues Below Consensus

August 7, 2019 7:27 AM EDT Send to a Friend
Moderna (NASDAQ: MRNA) reported Q2 revenue for the quarter came in at $13.08 million versus the consensus estimate of $18.8 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login